Published in Proc Natl Acad Sci U S A on April 27, 1999
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J (2004) 6.90
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res (2002) 6.64
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev (2009) 3.17
Efficient active transport of gene nanocarriers to the cell nucleus. Proc Natl Acad Sci U S A (2003) 2.52
Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano (2009) 2.36
Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A (2002) 2.00
Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum dot-FRET. Mol Ther (2008) 1.76
A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery. Mol Pharm (2009) 1.68
Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET. J Control Release (2006) 1.64
Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophys J (2003) 1.50
Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells. Pharm Res (2007) 1.39
Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles. Biochem J (2003) 1.37
Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures. AAPS PharmSci (2002) 1.36
Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater (2011) 1.33
Amphiphilic block copolymers enhance cellular uptake and nuclear entry of polyplex-delivered DNA. Bioconjug Chem (2008) 1.31
Scanning surface confocal microscopy for simultaneous topographical and fluorescence imaging: application to single virus-like particle entry into a cell. Proc Natl Acad Sci U S A (2002) 1.24
Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery. J R Soc Interface (2009) 1.22
Gene delivery by cationic lipid vectors: overcoming cellular barriers. Eur Biophys J (2006) 1.20
Magnetic nanoparticles as targeted delivery systems in oncology. Radiol Oncol (2011) 1.19
Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acids Res (2000) 1.16
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells. BMC Biotechnol (2013) 1.13
Quantification of plasmid DNA copies in the nucleus after lipoplex and polyplex transfection. J Control Release (2009) 1.07
Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery. J Control Release (2006) 1.06
Physical non-viral gene delivery methods for tissue engineering. Ann Biomed Eng (2012) 1.06
Reducible cationic lipids for gene transfer. Biochem J (2001) 1.02
Diblock copolymers with tunable pH transitions for gene delivery. Biomaterials (2011) 1.01
Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field. Nucleic Acids Res (2006) 1.01
Polyethyleneimine-mediated transfection of cultured postmitotic neurons from rat sympathetic ganglia and adult human retina. BMC Neurosci (2001) 0.98
Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery. Int J Pharm (2010) 0.97
Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid. Biomacromolecules (2012) 0.96
Nuclear delivery of NFkappaB-assisted DNA/polymer complexes: plasmid DNA quantitation by confocal laser scanning microscopy and evidence of nuclear polyplexes by FRET imaging. Nucleic Acids Res (2008) 0.93
Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine. BMC Cancer (2009) 0.91
Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice. BMC Biotechnol (2008) 0.90
Intracellular trafficking of nucleic acids. Expert Opin Drug Deliv (2004) 0.90
Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies. Anal Biochem (2005) 0.89
Nuclear entry of hyperbranched polylysine nanoparticles into cochlear cells. Int J Nanomedicine (2011) 0.89
Cationic lipid-coated PEI/DNA polyplexes with improved efficiency and reduced cytotoxicity for gene delivery into mesenchymal stem cells. Int J Nanomedicine (2012) 0.89
Understanding nonviral nucleic acid delivery with quantum dot-FRET nanosensors. Nanomedicine (Lond) (2012) 0.88
Bioconjugation of oligonucleotides for treating liver fibrosis. Oligonucleotides (2007) 0.88
Polyethyleneimine mediated DNA transfection in schistosome parasites and regulation of the WNT signaling pathway by a dominant-negative SmMef2. PLoS Negl Trop Dis (2013) 0.87
Structure and biological activity of pathogen-like synthetic nanomedicines. Nanomedicine (2011) 0.87
Synergistic effect of ultrasound and PEI on DNA transfection in vitro. J Control Release (2006) 0.87
Non-viral DNA delivery from porous hyaluronic acid hydrogels in mice. Biomaterials (2014) 0.86
Combinatorial and rational approaches to polymer synthesis for medicine. Adv Drug Deliv Rev (2008) 0.86
Differential intracellular distribution of DNA complexed with polyethylenimine (PEI) and PEI-polyarginine PTD influences exogenous gene expression within live COS-7 cells. Genet Vaccines Ther (2007) 0.85
Polymeric nucleic acid vehicles exploit active interorganelle trafficking mechanisms. ACS Nano (2012) 0.85
Large uptake of titania and iron oxide nanoparticles in the nucleus of lung epithelial cells as measured by Raman imaging and multivariate classification. Biophys J (2013) 0.84
Codelivery of DNA and siRNA via arginine-rich PEI-based polyplexes. Mol Pharm (2015) 0.84
Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor. Nucleic Acids Res (2001) 0.84
Exploring the mechanism of plasmid DNA nuclear internalization with polymer-based vehicles. Mol Pharm (2012) 0.84
Therapeutic potential of RNA interference in pain medicine. Open Pain J (2009) 0.84
Polyethylenimine-mediated gene delivery to the lung and therapeutic applications. Drug Des Devel Ther (2009) 0.84
Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides. J Nanobiotechnology (2009) 0.83
Real-time gene delivery vector tracking in the endo-lysosomal pathway of live cells. Microsc Res Tech (2011) 0.83
Effective non-viral delivery of siRNA to acute myeloid leukemia cells with lipid-substituted polyethylenimines. PLoS One (2012) 0.83
The heterogeneous nature of polyethylenimine-DNA complex formation affects transient gene expression. Cytotechnology (2009) 0.82
2007 AIChE Alpha Chi Sigma Award: From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering. AIChE J (2008) 0.82
Degradable poly(amino ester) based on poly(ethylene glycol) dimethacrylate and polyethylenimine as a gene carrier: molecular weight of PEI affects transfection efficiency. J Mater Sci Mater Med (2009) 0.81
Importin-7 mediates nuclear trafficking of DNA in mammalian cells. Traffic (2012) 0.81
Probing the in vitro mechanism of action of cationic lipid/DNA lipoplexes at a nanometric scale. Nucleic Acids Res (2010) 0.80
Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology. Int J Mol Sci (2012) 0.80
Biodegradable branched polycationic polymers with varying hydrophilic spacers for nonviral gene delivery. Biomacromolecules (2009) 0.80
Delivery of nucleic acids and nanomaterials by cell-penetrating peptides: opportunities and challenges. Biomed Res Int (2015) 0.80
Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization. Nucleic Acids Res (2009) 0.80
DNA nuclear targeting sequences for non-viral gene delivery. Pharm Res (2011) 0.80
Correlating intracellular nonviral polyplex localization with transfection efficiency using high-content screening. Biotechnol Prog (2015) 0.79
Effect of molecular weight of polyethyleneimine on loading of CpG oligodeoxynucleotides onto flake-shell silica nanoparticles for enhanced TLR9-mediated induction of interferon-α. Int J Nanomedicine (2012) 0.79
Biscarbamate cross-linked low molecular weight Polyethylenimine polycation as an efficient intra-cellular delivery cargo for cancer therapy. J Nanobiotechnology (2014) 0.79
Non-viral nucleic acid containing nanoparticles as cancer therapeutics. Expert Opin Drug Deliv (2016) 0.79
Tracking the pathway of calcium phosphate/DNA nanoparticles during cell transfection by incorporation of red-fluorescing tetramethylrhodamine isothiocyanate-bovine serum albumin into these nanoparticles. J Biol Inorg Chem (2006) 0.79
An electroporation protocol for efficient DNA transfection in PC12 cells. Cytotechnology (2013) 0.79
Glycotargeting to improve cellular delivery efficiency of nucleic acids. Glycoconj J (2007) 0.79
Polyplex exposure inhibits cell cycle, increases inflammatory response, and can cause protein expression without cell division. Mol Pharm (2013) 0.79
AAV2 production with optimized N/P ratio and PEI-mediated transfection results in low toxicity and high titer for in vitro and in vivo applications. J Virol Methods (2013) 0.79
Iron (III) citrate inhibits polyethylenimine-mediated transient transfection of Chinese hamster ovary cells in serum-free medium. Cytotechnology (2009) 0.79
Magnetofection Mediated Transient NANOG Overexpression Enhances Proliferation and Myogenic Differentiation of Human Hair Follicle Derived Mesenchymal Stem Cells. Bioconjug Chem (2015) 0.79
Optimizing the transient transfection process of HEK-293 suspension cells for protein production by nucleotide ratio monitoring. Cytotechnology (2013) 0.78
Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery. Int J Nanomedicine (2013) 0.78
Delivering factors for reprogramming a somatic cell to pluripotency. Int J Stem Cells (2012) 0.77
Virus-Inspired Self-Assembly Nanofibers with Aggregation-Induced Emission for Highly Efficient and Visible Gene Delivery. ACS Appl Mater Interfaces (2017) 0.77
Polyplex Evolution: Understanding Biology, Optimizing Performance. Mol Ther (2017) 0.76
Poly(2-aminoethyl methacrylate) with well-defined chain length for DNA vaccine delivery to dendritic cells. Biomacromolecules (2011) 0.76
Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer. Int J Nanomedicine (2015) 0.76
Quantitative comparison between poly(L-arginine) and poly(L-lysine) at each step of polyplex-based gene transfection using a microinjection technique. Sci Technol Adv Mater (2012) 0.75
Spatiotemporal cellular imaging of polymer-pDNA nanocomplexes affords in situ morphology and trafficking trends. Mol Pharm (2013) 0.75
Multilayered Nanoparticles for Gene Delivery Used to Reprogram Human Foreskin Fibroblasts to Neurospheres. Tissue Eng Part C Methods (2015) 0.75
NF-κB decoy polyplexes decrease P-glycoprotein-mediated multidrug resistance in colorectal cancer cells. Cancer Gene Ther (2016) 0.75
Non-viral gene therapy that targets motor neurons in vivo. Front Mol Neurosci (2014) 0.75
Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery. Int J Nanomedicine (2016) 0.75
Triolein-based polycation lipid nanocarrier for efficient gene delivery: characteristics and mechanism. Int J Nanomedicine (2011) 0.75
Effects of dendritic core-shell glycoarchitectures on primary mesenchymal stem cells and osteoblasts obtained from different human donors. J Nanobiotechnology (2015) 0.75
Cross-linked polyethylenimine-tripolyphosphate nanoparticles for gene delivery. Int J Nanomedicine (2014) 0.75
Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA. Int J Nanomedicine (2017) 0.75
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A (1983) 7.55
Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry (1996) 4.06
The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther (1998) 2.19
Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem (1998) 1.98
A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther (1996) 1.91
Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther (1996) 1.74
Polyethyleneimine is an effective permeabilizer of gram-negative bacteria. Microbiology (1997) 1.47
Effects of polyethyleneimine on endocytosis and lysosome stability. Biochem Pharmacol (1998) 1.28
Permeabilizing action of polyethyleneimine on Salmonella typhimurium involves disruption of the outer membrane and interactions with lipopolysaccharide. Microbiology (1998) 1.24
Polyethylenimine-mediated DNA transfection of peripheral and central neurons in primary culture: probing Ca2+ channel structure and function with antisense oligonucleotides. Mol Cell Neurosci (1996) 1.17
Nonviral gene delivery to the rat kidney with polyethylenimine. Hum Gene Ther (1997) 1.13
Prostacyclin expression by a continuous human cell line derived from vascular endothelium. Blood (1986) 1.05
The fusogenic effect of synthetic polycations on negatively charged lipid bilayers. J Biochem (1986) 1.03
Low pH induced membrane fusion of lipid vesicles containing proton-sensitive polymer. Biochemistry (1987) 0.91
Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med (1993) 5.14
Poly(ethylenimine) and its role in gene delivery. J Control Release (1999) 3.78
Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation (1997) 3.27
Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost (1993) 3.12
Review: tissue engineering for regeneration of articular cartilage. Biomaterials (2000) 2.40
Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res (1999) 2.33
Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 2.32
A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet (1974) 2.29
Detailed alignment of saccharum and sorghum chromosomes: comparative organization of closely related diploid and polyploid genomes. Genetics (1998) 2.24
Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res (1997) 2.21
Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation (1999) 2.08
Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials (2001) 1.94
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost (1989) 1.86
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76
Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials (2000) 1.73
Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol (2001) 1.73
Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials (1998) 1.69
Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials (2001) 1.65
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci U S A (1999) 1.60
Water immersion versus standard colonoscopy insertion technique: randomized trial shows promise for minimal sedation. Endoscopy (2010) 1.56
Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res (2000) 1.50
Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis. Circulation (1999) 1.49
Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura. Lancet (1981) 1.49
State of complementary and alternative medicine in cardiovascular, lung, and blood research: executive summary of a workshop. Circulation (2001) 1.47
Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun (1994) 1.44
Growth factor delivery for tissue engineering. Pharm Res (2000) 1.42
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis (1991) 1.40
Biomaterials and bone mechanotransduction. Biomaterials (2001) 1.39
Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther (1999) 1.31
Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration. Biomaterials (1998) 1.30
In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. J Biomed Mater Res (1999) 1.30
Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules (2001) 1.26
Polymer concepts in tissue engineering. J Biomed Mater Res (1998) 1.25
Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer. Clin Cancer Res (2001) 1.25
Growth factor-loaded scaffolds for bone engineering. J Control Release (2005) 1.25
In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials (1996) 1.24
Synthesis and properties of photocross-linked poly(propylene fumarate) scaffolds. J Biomater Sci Polym Ed (2001) 1.24
Metastatic tumors of the hand: a report of six cases. J Hand Surg Am (1978) 1.24
Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage (2006) 1.24
Review: Hydrogels for cell immobilization. Biotechnol Bioeng (1996) 1.21
Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res (1995) 1.20
Increased platelet aggregates in patients with transient ischemic attacks. Stroke (1975) 1.20
Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J Cell Biochem (1998) 1.19
Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant (1994) 1.17
Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care (1999) 1.16
Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials (1998) 1.16
Aspirin and salicylate: An old remedy with a new twist. Circulation (2000) 1.15
Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release (2005) 1.14
Fallibility of the clinical diagnosis of venous thrombosis. JAMA (1975) 1.14
The importance of new processing techniques in tissue engineering. MRS Bull (1996) 1.14
In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med (2006) 1.12
In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res (1998) 1.12
Biological activity of rhBMP-2 released from PLGA microspheres. J Biomech Eng (2000) 1.12
Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem (2001) 1.12
Marrow stromal osteoblast function on a poly(propylene fumarate)/beta-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials (2000) 1.11
The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. Tissue Eng (1995) 1.11
Growing new organs. Sci Am (1999) 1.10
Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity. Biochem Biophys Res Commun (1995) 1.10
In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials (1999) 1.10
Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb (1993) 1.08
Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Arterioscler Thromb (1993) 1.08
Crosslinking characteristics of an injectable poly(propylene fumarate)/beta-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res (1999) 1.07
Fabrication of biodegradable polymer scaffolds to engineer trabecular bone. J Biomater Sci Polym Ed (1995) 1.07
Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications. Thromb Haemost (1976) 1.06
Cysteine 184 of endothelial nitric oxide synthase is involved in heme coordination and catalytic activity. J Biol Chem (1994) 1.06
Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed (2006) 1.06
Smoking cessation among Hong Kong Chinese smokers attending hospital as outpatients: impact of doctors' advice, successful quitting and intention to quit. Asia Pac J Public Health (2004) 1.06
Bone tissue engineering. Nat Med (1995) 1.05
Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation (1995) 1.05
Injectable biodegradable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-dimethacrylate. Biomaterials (2000) 1.05
In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres. J Biomed Mater Res A (2009) 1.05
Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds. Biomaterials (1999) 1.05
In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mater Res (1999) 1.04
Platelet adhesion on a bioresorbable poly(propylene fumarate-co-ethylene glycol) copolymer. Biomaterials (1999) 1.03
Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. Induction of de novo synthesis of prostaglandin H synthase. J Clin Invest (1988) 1.03
Metastatic tumors of the foot. South Med J (1978) 1.02
Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells. J Biol Chem (2000) 1.01
Synthesis of poly(propylene fumarate) by acylation of propylene glycol in the presence of a proton scavenger. J Biomater Sci Polym Ed (1999) 1.01
Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann Intern Med (1978) 1.00
Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res (1994) 1.00
Endothelial nitric-oxide synthase. Evidence for bidomain structure and successful reconstitution of catalytic activity from two separate domains generated by a baculovirus expression system. J Biol Chem (1996) 1.00
Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase gamma /Janus kinase 2/MEK-1-dependent pathway. J Biol Chem (2001) 1.00
Recent progress in gene delivery using non-viral transfer complexes. J Control Release (2001) 1.00
Mechanical properties of a biodegradable bone regeneration scaffold. J Biomech Eng (2000) 0.99
Fabrication of pliable biodegradable polymer foams to engineer soft tissues. Cell Transplant (1997) 0.99
Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost (1994) 0.98
In vitro degradation of porous poly(L-lactic acid) foams. Biomaterials (2000) 0.98
Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J Biomed Mater Res (2000) 0.97
Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem (1995) 0.97
TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. J Bone Joint Surg Am (2001) 0.97
Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery. J Biomed Mater Res (1997) 0.97
Characterization of the roles of the 594-645 region in human endothelial nitric-oxide synthase in regulating calmodulin binding and electron transfer. J Biol Chem (2000) 0.96